JD HEALTH
06618
JD-SW
09618
BEKE-W
02423
TRIP.COM-S
09961
NTES-S
09999
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 4.12%54.17M | 16.17%108.38M | -4.50%78.81M | -7.26%52.03M | -4.42%26.34M | 8.48%93.3M | 40.51%82.52M | 48.00%56.1M | 48.57%27.56M | 11.98%86.01M |
Operating income | 4.12%54.17M | 16.17%108.38M | -4.50%78.81M | -7.26%52.03M | -4.42%26.34M | 8.48%93.3M | 40.51%82.52M | 48.00%56.1M | 48.57%27.56M | 11.98%86.01M |
Cost of sales | -4.07%-29.44M | -17.79%-58.26M | 19.17%-42.24M | 23.25%-28.29M | 18.77%-14.59M | -6.93%-49.46M | -55.66%-52.26M | -77.68%-36.86M | -74.65%-17.96M | 6.37%-46.26M |
Operating expenses | -4.07%-29.44M | -17.79%-58.26M | 19.17%-42.24M | 23.25%-28.29M | 18.77%-14.59M | -6.93%-49.46M | -55.66%-52.26M | -77.68%-36.86M | -74.65%-17.96M | 6.37%-46.26M |
Gross profit | 4.17%24.73M | 14.33%50.12M | 20.82%36.57M | 23.38%23.74M | 22.43%11.75M | 10.28%43.84M | 20.28%30.26M | 12.12%19.24M | 16.14%9.6M | 45.06%39.75M |
Employee expense | 4.64%-12.88M | -4.35%-27.28M | -3.66%-20.14M | -7.32%-13.51M | -12.57%-6.89M | -7.39%-26.14M | -10.62%-19.43M | -14.65%-12.59M | -15.20%-6.12M | -33.45%-24.35M |
Depreciation and amortization | 21.86%-3.11M | 30.43%-7.81M | 28.94%-5.97M | 29.06%-3.98M | 29.99%-1.97M | 11.38%-11.23M | 4.64%-8.4M | -3.85%-5.61M | -3.30%-2.81M | -34.20%-12.67M |
Impairment and provision | ---- | 86.31%-801K | ---- | ---- | ---- | 43.67%-5.85M | ---- | ---- | ---- | ---10.39M |
-Impairment of property, machinery and equipment | ---- | 68.49%-801K | ---- | ---- | ---- | 41.37%-2.54M | ---- | ---- | ---- | ---4.34M |
-Other impairment is provision | ---- | ---- | ---- | ---- | ---- | 45.31%-3.31M | ---- | ---- | ---- | ---6.05M |
Special items of operating profit | -1.81%-9.39M | -11.59%-16.77M | -44.63%-13.88M | -39.10%-9.22M | -17.75%-4.55M | 16.22%-15.02M | 15.31%-9.6M | 21.89%-6.63M | 6.65%-3.86M | -181.17%-17.93M |
Operating profit | 78.17%-648K | 82.40%-2.54M | 52.20%-3.43M | 46.83%-2.97M | 48.37%-1.65M | 43.68%-14.41M | 42.88%-7.17M | 27.54%-5.58M | 18.25%-3.19M | -284.24%-25.58M |
Financing cost | 30.57%-159K | 20.61%-439K | 21.08%-337K | 22.11%-229K | 21.19%-119K | -2.03%-553K | -17.63%-427K | -30.67%-294K | -52.53%-151K | 23.12%-542K |
Earning before tax | 74.76%-807K | 80.11%-2.98M | 50.45%-3.76M | 45.59%-3.2M | 47.14%-1.77M | 42.73%-14.96M | 41.18%-7.59M | 25.89%-5.88M | 16.50%-3.34M | -254.81%-26.12M |
Tax | ---- | -109.24%-129K | ---- | ---- | ---- | 20,042.86%1.4M | 111.20%120K | -88.49%71K | -79.43%43K | -100.58%-7K |
After-tax profit from continuing operations | 74.76%-807K | 77.11%-3.1M | 49.66%-3.76M | 44.93%-3.2M | 46.45%-1.77M | 48.09%-13.56M | 46.55%-7.47M | 20.61%-5.81M | 13.03%-3.3M | -324.43%-26.13M |
Earning after tax | 74.76%-807K | 77.11%-3.1M | 49.66%-3.76M | 44.93%-3.2M | 46.45%-1.77M | 48.09%-13.56M | 46.55%-7.47M | 20.61%-5.81M | 13.03%-3.3M | -324.43%-26.13M |
Minority profit | -60.41%-393K | 102.39%95K | 84.10%-155K | 59.44%-245K | 52.63%-252K | -32.99%-3.98M | 26.14%-975K | -22.27%-604K | -190.71%-532K | -609.72%-3M |
Profit attributable to shareholders | 85.98%-414K | 66.61%-3.2M | 44.49%-3.61M | 43.24%-2.95M | 45.26%-1.51M | 58.59%-9.58M | 48.67%-6.5M | 23.72%-5.2M | 23.36%-2.77M | -303.44%-23.13M |
Basic earnings per share | 85.71%-0.0003 | 66.18%-0.0023 | 43.48%-0.0026 | 43.24%-0.0021 | 45.00%-0.0011 | 58.79%-0.0068 | 48.89%-0.0046 | 24.49%-0.0037 | 23.08%-0.002 | -302.44%-0.0165 |
Diluted earnings per share | 85.71%-0.0003 | 66.18%-0.0023 | 43.48%-0.0026 | 43.24%-0.0021 | 45.00%-0.0011 | 58.79%-0.0068 | 48.89%-0.0046 | 24.49%-0.0037 | 23.08%-0.002 | -302.44%-0.0165 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.